Bladder Angiotensin-II Receptors: Characterization and Alteration in Bladder Outlet Obstruction

European Urology

Volumn 55, Issue 2, 2009, Pages 482-490

  Yamada, Shizuo ^a   Takeuchi, Chihiro ^a   Oyunzul, Luvsandorj ^a   Ito, Yoshihiko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Angiotensin II receptors; Bladder; Bladder outlet obstruction; Telmisartan

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; RADIOLIGAND; TELMISARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER NECK STENOSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SINGLE DRUG DOSE;

ADMINISTRATION, ORAL; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; DISEASE MODELS, ANIMAL; FEMALE; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION;

EID: 57749118574     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.03.015     Document Type: Article

References (29)

1. Cheng E.Y., Grammatopoulos T., Lee C., et al. Angiotensin II and basic fibroblast growth factor induce neonatal bladder stromal cell mitogenesis. J Urol 156 (1996) 593-597
2. Park J.M., Borer J.G., Freeman M.R., and Peters C.A. Stretch activates heparin-binding EGF-like growth factor expression in bladder smooth muscle cells. Am J Physiol 275 (1998) C1247-C1254
3. Kato H., Suzuki H., Tajima S., et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9 (1991) 17-22
4. Gosling J.A., Gilpin S.A., Dixon J.S., and Gilpin C.J. Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction. J Urol 136 (1986) 501-504
5. 3H-thymidine uptake by the rat urinary bladder after partial outflow obstruction. Neurourol Urodyn 13 (1994) 63-69
6. Maruyama S., Kurosawa S., Takagi Y., et al. Urodynamics and bladder muscarinic receptors in rats with cerebral infarction and bladder outlet obstruction. Neurosci Lett 414 (2007) 80-84
7. Cheng E.Y., Lee C., Decker R.S., et al. Captopril (an inhibitor of angiotensin converting enzyme) inhibits obstructive changes in the neonatal rabbit bladder. Urology 50 (1997) 465-471
8. Phull H., Salkini M., Escobar C., et al. The role of angiotensin II in stress urinary incontinence: a rat model. Neurourol Urodyn 26 (2007) 81-88
9. Tanabe N., Ueno A., and Tsujimoto G. Angiotensin II receptors in the rat urinary bladder smooth muscle: type 1 subtype receptors mediate contractile responses. J Urol 150 (1993) 1056-1059
10. 1 receptor antagonist in rats, in relation to its plasma concentration and hypotensive effect. Pharm Res 15 (1998) 911-917
11. 3H]WB4101: effect of 6-hydroxydopamine treatment. J Pharmacol Exp Ther 215 (1980) 176-185
12. Palmer L.S., Lee C., Decker L.R., et al. The effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on obstructed rat bladder. J Urol 158 (1997) 1100-1104
13. Persson K., Randita R.K., Waldeck K., et al. Angiotensin II and bladder obstruction in the rat: influence on hypertrophic growth and contractility. Am J Physiol 271 (1996) R1186-R1192
14. Waldeck K., Lindberg B.F., Persson K., et al. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study. Br J Pharmacol 121 (1997) 1081-1086
15. Lam D.S.H., Dias L.S., Moore K.H., et al. Angiotensin II in child urinary bladder: functional and autoradiographic studies. Br J Urol 86 (2000) 494-501
16. Zhang P., Zhang Y., Chen X., Li R., Yin J., and Zhong D. Pharmacokinetics of telmisartan in healthy Chinese subjects after oral administration of two dosage levels. Arzneimittelforschung 56 (2006) 569-573
17. 1-adrenoceptor occupancy in the human prostate from plasma concentration of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia. Biol Pharm Bull 30 (2007) 1237-1241
18. Hatada T, Noguchi M, Tobu S, Mori K, Matsuo M, Kanetaka H. Differential expression of angiotensin II type-1 receptor in the rat detrusor muscle with partial bladder outlet obstruction and diabetes mellitus model [abstract]. 37th Annual Meeting of Int. Continence Soc. (Rotterdam, Netherlands). 2007. Abstract 390.
19. Andersson K.E., Hedlund H., and Stahl M. Contractions induced by angiotensin I, angiotensin II and bradykinin in isolated smooth muscle from the human detrusor. Acta Physiol Scand 145 (1992) 253-259
20. Erspamer V., Ronzoni G., and Falconieri-Erspamer G. Effects of active peptides on the isolated muscle of the human urinary bladder. Invest Urol 18 (1981) 302-304
21. Saito M., Kondo A., Kato T., and Miyake K. Response of the human urinary bladder to angiotensins: a comparison between neurogenic and control bladders. J Urol 149 (1993) 408-411
22. Yamada S., Isogai M., Okudaira H., and Hayashi E. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. J Pharmacol Exp Ther 226 (1983) 519-525
23. Greenland J.E., and Brading A.F. Urinary bladder blood flow changes during the micturition cycle in a conscious pig model. J Urol 156 (1996) 1858-1861
24. Steers W.D., and de Groat W.C. Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J Urol 140 (1988) 864-871
25. Schröder A., Chichester P., Kogan B.A., et al. Effect of chronic bladder outlet obstruction on blood flow of the rabbit bladder. J Urol 165 (2001) 640-646
26. Hao K., Chen Y.C., Cao Y.G., et al. Pharmacokinetic-pharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats. Acta Pharmacol Sin 28 (2007) 738-743
27. Imayama I., Ichiki T., Inanaga K., et al. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor γ. Cardiovasc Res 72 (2006) 184-190
28. Ernsberger P., and Koletsky R.J. Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?. Current Opinion in Pharmacology 7 (2007) 140-145
29. Mizuno K., Tani M., Hashimoto S., et al. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. Life Sciences 51 (1992) 367-374